T. N refers to a member; n refers to a member; n refers to a member; n refers to a member; n refers to a member; n refers to a member; n refers to a member; n refers to a member; n refers to a drug; n refers to a medicament; n refers to CI amp; amp; amp; oacute; oral refers to a receiver's medicine bottle, including: farnesoide x (FXR) choline, amp; Aacute; Aacute; di2 amp; amp; NDAs; [(1R, 3R, 5S) amp) amp; amp; NDAs; NDAs; NDAs; NDAs; NDAs; NDAs; NDAs; NDAs; MDAS; mp; (; pillah;; pillah;; (; pillah;; (; pillah;; (; pillah;; (; pillah;; (; pill; mp; (; mp;; pillah;; mp; (; mp;; mp;; mp;; mp;; 3 amp; ndash; [2 amp; ndash; 1.2 amp; endash; 1.2 amp; endash; endash; andash; 1.2 amp; endash; endash; erdash; 4 amp; 4 amp; 4 amp; endash; idash; yizhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengzhengin fact, it is acceptable that one of the drugs and amp; eacute; is effective,And at least one precursor L amp; Iacute; request; a C amp; Aacute; psula for administration; oacute; N, including CI amp; oacute; n medicament amp; eacute; Utica; Utica; the use of such compound CI amp; oacute; n Pharmacopoeia amp; eacute; acute; for the effective treatment of an emotion and amp; oacute; n or disorder mediated by FXR; And a preparation process; oacute; n; oacute; n pharmacy and amp; eacute; Utica. lt; P gt;<;p&